a16z Leads $33M for Telepatia’s AI Healthcare in LatAm

a16z Backs Telepatia’s $33M Series A Round

Andreessen Horowitz (a16z) has announced its lead investment in Telepatia’s $33 million Series A funding round. The AI-native clinical platform aims to address critical clinician shortages across Latin America.

Founded by Nicolás Abad, Telepatia provides AI documentation, clinical decision support, and AI healthcare employees, including AI doctors and nurses. The platform’s inception was inspired by Abad’s father, a Colombian physician whose preventable death highlighted the need for advanced medical error prevention.

Impact and Expansion Across Latin America

• Telepatia has rapidly deployed across 25+ hospital systems since July 2025.
• It currently serves 14 million patients in Brazil, Colombia, and Mexico.
• The platform has increased protocol adherence from 84% to 99%.
• Physicians recover 1.7 hours daily, dedicating more time to patient care.
• Notably, Telepatia has prevented 60,000 medical errors in real time.

Latin America’s ‘clean slate’ in healthcare technology allows it to implement cutting-edge AI solutions without legacy system hurdles. The investment round also saw participation from prominent figures like Palantir CTO Shyam Sankar, Rappi founder Simón Borrero, and Nubank founder David Vélez.

Future Vision: AI for Medical Breakthroughs

Nicolás Abad envisions Telepatia earning a Nobel Prize in Medicine for Latin America. He believes AI-powered breakthroughs are the next frontier in medical science, similar to AI’s recent recognition in Physics and Chemistry Nobel Prizes.